ginkgolide-B
Star0
Identification
- Generic Name
- ginkgolide-B
- DrugBank Accession Number
- DB06744
- Background
Not Available
- Type
- Small Molecule
- Groups
- Nutraceutical
- Structure
- Weight
- Average: 424.3986
Monoisotopic: 424.136946988 - Chemical Formula
- C20H24O10
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as ginkgolides and bilobalides. These are diterpene lactones with a structure based either on the gingkolide or the bilobalide skeleton. The ginkgolide skeleton is a very rigid structure consisting of hexacyclic C20 trilactone. The cis-fused F/A/D/C ring junction forms an empty semi-ball hole, the D ring contains a cage form tetrahydrofuran ring which occupies the center of the empty hole, and the oxygen atoms of the D,C and F ring and 10-hydroxyl group consist of an analogous crown ether structure.
- Kingdom
- Organic compounds
- Super Class
- Lipids and lipid-like molecules
- Class
- Prenol lipids
- Sub Class
- Terpene lactones
- Direct Parent
- Ginkgolides and bilobalides
- Alternative Parents
- Diterpenoids / Tricarboxylic acids and derivatives / Furofurans / Gamma butyrolactones / Tetrahydrofurans / Tertiary alcohols / Secondary alcohols / Cyclic alcohols and derivatives / Carboxylic acid esters / Polyols show 5 more
- Substituents
- Acetal / Alcohol / Aliphatic heteropolycyclic compound / Carbonyl group / Carboxylic acid derivative / Carboxylic acid ester / Cyclic alcohol / Diterpenoid / Furofuran / Gamma butyrolactone show 13 more
- Molecular Framework
- Aliphatic heteropolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- SQOJOAFXDQDRGF-MMQTXUMRSA-N
- InChI
- InChI=1S/C20H24O10/c1-6-12(23)28-11-9(21)18-8-5-7(16(2,3)4)17(18)10(22)13(24)29-15(17)30-20(18,14(25)27-8)19(6,11)26/h6-11,15,21-22,26H,5H2,1-4H3/t6-,7+,8-,9+,10+,11+,15+,17+,18+,19-,20-/m1/s1
- IUPAC Name
- (1R,3R,6R,7S,8S,10R,11R,12R,13S,16S,17R)-8-tert-butyl-6,12,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-5,15,18-trione
- SMILES
- C[C@@H]1C(=O)O[C@H]2[C@H](O)[C@@]34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O
References
- General References
- Wang SJ, Chen HH: Ginkgolide B, a constituent of Ginkgo biloba, facilitates glutamate exocytosis from rat hippocampal nerve terminals. Eur J Pharmacol. 2005 May 9;514(2-3):141-9. [Article]
- External Links
- PubChem Compound
- 6324617
- PubChem Substance
- 99443280
- ChemSpider
- 21105603
- BindingDB
- 50251276
- ChEMBL
- CHEMBL514432
- ZINC
- ZINC000008552017
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 5.21 mg/mL ALOGPS logP 0.49 ALOGPS logP -0.58 Chemaxon logS -1.9 ALOGPS pKa (Strongest Acidic) 11.71 Chemaxon pKa (Strongest Basic) -3.5 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 7 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 148.82 Å2 Chemaxon Rotatable Bond Count 1 Chemaxon Refractivity 91.38 m3·mol-1 Chemaxon Polarizability 39.09 Å3 Chemaxon Number of Rings 6 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.7952 Blood Brain Barrier + 0.7395 Caco-2 permeable - 0.6884 P-glycoprotein substrate Substrate 0.5693 P-glycoprotein inhibitor I Non-inhibitor 0.7251 P-glycoprotein inhibitor II Non-inhibitor 0.9375 Renal organic cation transporter Non-inhibitor 0.9384 CYP450 2C9 substrate Non-substrate 0.7957 CYP450 2D6 substrate Non-substrate 0.8535 CYP450 3A4 substrate Substrate 0.5679 CYP450 1A2 substrate Non-inhibitor 0.9307 CYP450 2C9 inhibitor Non-inhibitor 0.9341 CYP450 2D6 inhibitor Non-inhibitor 0.9449 CYP450 2C19 inhibitor Non-inhibitor 0.9528 CYP450 3A4 inhibitor Non-inhibitor 0.9335 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9699 Ames test Non AMES toxic 0.5883 Carcinogenicity Non-carcinogens 0.9065 Biodegradation Not ready biodegradable 0.9788 Rat acute toxicity 2.4970 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9961 hERG inhibition (predictor II) Non-inhibitor 0.9662
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-004i-0000900000-a8e7b6a67994278d3299 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-01b9-0009300000-4cb740ebb681275c8bbf Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-004i-0006900000-84e497373a644c403bb1 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-006y-0509300000-533f3c702f485dffaf5b Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-003r-0079300000-27861988193a1aa56f72 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-02tc-1900000000-dd61692ec581a33bf347 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 198.502126 predictedDarkChem Lite v0.1.0 [M-H]- 196.687526 predictedDarkChem Lite v0.1.0 [M-H]- 185.46439 predictedDeepCCS 1.0 (2019) [M+H]+ 198.312126 predictedDarkChem Lite v0.1.0 [M+H]+ 197.106226 predictedDarkChem Lite v0.1.0 [M+H]+ 187.52583 predictedDeepCCS 1.0 (2019) [M+Na]+ 198.046126 predictedDarkChem Lite v0.1.0 [M+Na]+ 196.259126 predictedDarkChem Lite v0.1.0 [M+Na]+ 193.91261 predictedDeepCCS 1.0 (2019)
Drug created at September 06, 2010 19:32 / Updated at June 12, 2020 16:52